EXAS


Roth Capital Bullish on EXACT Sciences Corporation (EXAS) as UNH Adds Cologuard to Its Commercial Coverage Guidelines

EXACT Sciences Corporation (NASDAQ:EXAS) shares rose over 10% in Wednesday’s trading session, following the news that the United Healthcare issued an updated preventative care services …

Analysts Raise Price Targets For Two Earnings Winners: EXACT Sciences Corporation (EXAS), Paypal Holdings Inc (PYPL)

Earnings season continued to have an impact on individual stocks, and EXACT Sciences Corporation (NASDAQ:EXAS) and Paypal Holdings Inc (NASDAQ:PYPL) were among the …

Healthcare Analysts Weigh in on Two Buzzing Stocks: Ariad Pharmaceuticals, Inc. (ARIA), EXACT Sciences Corporation (EXAS)

Ariad Pharmaceuticals, Inc. Investors in Ariad Pharmaceuticals, Inc.

Canaccord Remains Bullish on EXACT Sciences Corporation (EXAS) Despite Disappointing Outlook

EXACT Sciences Corporation (NASDAQ:EXAS) shares fell almost 15% yesterday after the molecular diagnostics company posted third-quarter earnings yesterday. Yet, Canaccord analyst Mark Massaro …

Roth Capital Analyst Weighs in on EXACT Sciences Corporation (EXAS) Following 2Q Results

Roth Capital analyst Chris Lewis remains neutral on molecular diagnostics company EXACT Sciences Corporation (NASDAQ:EXAS). Following solid second quarter earnings results, but with …

Stock Update (NASDAQ:EXAS): EXACT Sciences Corporation Announces Agreement to Sell 7,000,000 Common Shares

EXACT Sciences Corporation (NASDAQ:EXAS) announced an agreement to sell 7,000,000 shares of its common stock to Jefferies LLC, Robert W. Baird & Co.

BTIG Analyst Has Positive Outlook on EXACT Sciences Corporation (EXAS) Following Earnings

Analyst Sean Lavin of BTIG was encouraged with EXACT Sciences Corporations (NASDAQ:EXAS) latest earnings report. EXACT’s second quarter saw an increase in the …

Company Update (NASDAQ:EXAS): EXACT Sciences Corporation Completes 54,000 Cologuard Tests during the Second Quarter

EXACT Sciences Corporation (NASDAQ:EXAS) announced that the company generated revenues of $21.2 million during the second quarter ended June 30, 2016, representing a …

William Blair Weighs In on Two Biotech Stocks: SAGE Therapeutics Inc (SAGE), EXACT Sciences Corporation (EXAS)

William Blair analysts discuss biotech companies SAGE Therapeutics Inc (NASDAQ:SAGE) and EXACT Sciences Corporation (NASDAQ:EXAS) after developments that will improve the company’s future outlook. …

Baird Bullish on EXACT Sciences Corporation (EXAS) and Cerus Corporation (CERS); Here’s Why

Analyst Catherine Ramsey of Robert W. Baird is bullish on EXACT Sciences Corporation (NASDAQ:EXAS) and Cerus Corporation (NASDAQ:CERS) following positive developments surrounding their products.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts